Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
29.63 CNY | +0.44% | -3.83% | -43.08% |
Kurzporträt
Mitarbeiterzahl: 3 370
Umsatz nach Geschäftsbereich
CNY in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Molecular Building Blocks and Tool Compounds - Product
53,3
%
| 748 | 55,1 % | 1 003 | 53,3 % | +34.13% |
Active Pharmaceutical Ingredient and Intermediate, Preparations - Product
23,0
%
| 390 | 28,8 % | 432 | 23,0 % | +10.69% |
Active Pharmaceutical Ingredient and Intermediate, Preparations - Technical
16,2
%
| 131 | 9,6 % | 304 | 16,2 % | +132.51% |
Molecular Building Blocks and Tool Compounds - Technical
6,9
%
| 79 | 5,8 % | 129 | 6,9 % | +62.81% |
Other Business
0,6
%
| 10 | 0,7 % | 12 | 0,6 % | +19.63% |
Umsatz je Region
CNY in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
China
63,0
%
| 889 | 65,9 % | 1 177 | 63,0 % | +32.43% |
Overseas
37,0
%
| 460 | 34,1 % | 691 | 37,0 % | +50.46% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Qiang Gao
FOU | Founder | 51 | 30.09.06 |
Bao Fu Zheng
CEO | Chief Executive Officer | 45 | 30.09.06 |
Yu Chen Zhang
CHM | Chairman | 56 | 01.02.20 |
Min Li
DFI | Director of Finance/CFO | 43 | 01.03.09 |
Shuo Liang Li
CTO | Chief Tech/Sci/R&D Officer | 47 | 23.12.15 |
Xian Shu Zhang
BRD | Director/Board Member | 44 | 01.07.09 |
Hai Wang Liu
BRD | Director/Board Member | 42 | 01.12.06 |
Fei Min Jin
BRD | Director/Board Member | 58 | 01.07.16 |
Wen Jing Li
IRC | Investor Relations Contact | 32 | 01.07.15 |
Wei Hong Shen
SEC | Corporate Secretary | 38 | 01.05.08 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Bin Yuan
BRD | Director/Board Member | 43 | 20.12.19 |
Yun Chen
BRD | Director/Board Member | 38 | 23.12.15 |
Bao Fu Zheng
CEO | Chief Executive Officer | 45 | 30.09.06 |
Qiang Gao
FOU | Founder | 51 | 30.09.06 |
Shuo Liang Li
CTO | Chief Tech/Sci/R&D Officer | 47 | 23.12.15 |
Yao Gao
BRD | Director/Board Member | 43 | 20.12.19 |
Xing Xian Zhang
BRD | Director/Board Member | 51 | 20.12.19 |
Hai Wang Liu
BRD | Director/Board Member | 42 | 01.12.06 |
Yu Chen Zhang
CHM | Chairman | 56 | 01.02.20 |
Gu Xiao Dan
BRD | Director/Board Member | 41 | 06.01.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 150 387 339 | 62 305 471 ( 41,43 %) | 0 | 41,43 % |
Unternehmenskontakt
Shanghai Haoyuan Chemexpress Co. Ltd.
Building 3, Lane 1999 Zhangheng Road
201203, Shanghai
+
http://www.chemexpress.com.cnSektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
Jahresgewinne - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
-43.08% | 615 Mio. | |
-2.95% | 90.75 Mrd. | |
-1.97% | 39.03 Mrd. | |
-15.47% | 31.85 Mrd. | |
+62.74% | 26.26 Mrd. | |
-22.81% | 14.13 Mrd. | |
-8.82% | 12.87 Mrd. | |
-11.77% | 11.6 Mrd. | |
-45.97% | 10.91 Mrd. | |
+3.45% | 8.89 Mrd. |
- Börse
- Aktien
- 688131 Aktie
- Unternehmen Shanghai Haoyuan Chemexpress Co., Ltd.